Vol.

No.

June 07, 2019Jun 07, 2019

DOWNLOAD THE PDF

Cover Story

ASCO's mCODE seeks to compose lingua franca for cancer informatics

By Matthew Bin Han Ong and Paul Goldberg

The American Society of Clinical Oncology published a set of common standards for cancer data elements via an initiative dubbed mCODE.

Editorial Free

ASCO 2019 through art

By Paul Goldberg

Conversation with The Cancer Letter

ASCO's Miller: mCODE will improve downstream analytics with essential cancer data elements

By Paul Goldberg

Guest Editorial

Big Data for outcomes and clinical research:
major advance or improvement needed

By Roy B. Jones, Amar Chahal, Dianne Reeves, Gregory H. Jones and Charles S. Martinez

Free Obituary

Henry Lynch, pioneer of hereditary cancer detection, dies at 91

In Brief

Tony Kerlavage named director of NCI CBIIT

Jeff Shilling named NCI's chief information officer

Jeff Settleman named senior VP, group head of oncology R&D at Pfizer

RWJBarnabas Health and Rutgers Cancer Institute announce $750M cancer pavilion in New Brunswick

Hackensack Meridian Health opens Center for Discovery and Innovation

Indiana University and MSK researchers receive $4.1 million grant from Cancer Moonshot

Funding Opportunities

DoD kidney cancer funding opportunities for FY2019

Clinical Roundup

Study finds link between Medicaid expansion and equity in cancer care

Long-term survival benefit shown for metastatic melanoma patients treated with Tafinlar + Mekinist

Venclexta + Gazyva combination meets primary endpoint for CLL

Pembrolizumab found safe in treating cancer patients with HIV

BMS announces first presentation of results for Opdivo + Yervoy in hepatocellular carcinoma

Lymphoma trial finds combination targeted therapy effective prior to chemotherapy

Enfortumab vedotin produced tumor response rate of 44% in bladder cancer

Researchers identify three-drug combination curbing growth in melanoma

Taiho Oncology and Servier present Lonsurf data

Drugs & Targets

FDA grants Priority Review for daratumumab combination in multiple myeloma

Caris Life Sciences partners with Debiopharm International SA

NCI Trials

NCI Trials for June

The National Cancer Institute Cancer Therapy Evaluation Program approved the following clinical research studies last month.

PREVIOUS ISSUE

NEXT ISSUE